Sustainable Room-Temperature Sol–Gel Synthesis of Mesoporous Silica Nanoparticles from Sodium Silicate Using Ascorbic Acid and Nonionic Surfactants for Amoxicillin Removal from Water

Mesoporous silica nanoparticles (MSNs) are promising nanomaterials for many applications, including water remediation, owing to their high surface area, tunable mesoporosity, and modifiable silanol-rich surfaces. However, their conventional synthesis often relies on costly tetraethyl orthosilicate (TEOS), cationic surfactants, organic solvents, and energy-intensive hydrothermal processing. Herein, a facile sustainable room-temperature sol–gel route is reported using inexpensive sodium silicate as the silica source, L-ascorbic acid as a mild biodegradable acid catalyst, and a binary nonionic surfactant system, Triton X-100/polysorbate 80, as the structure-directing template. The method replaces alkoxysilanes and hazardous cationic templates and eliminates external heating. It enables the production of uniform spherical MSNs with a locally ordered mesoporous structure, high specific surface area up to 551.5 m2 g−1, and large pore volume up to 1.98 cm3 g−1. The adsorption capability of the optimized MSNs as nano-adsorbents was demonstrated using amoxicillin (AMX) as a model pharmaceutical contaminant. The optimized sample showed maximum AMX uptake at pH 5.0, followed pseudo-second-order kinetics, and fitted the Langmuir isotherm with a monolayer capacity of 91.3 mg g−1. In spiked water matrices, the optimized MSNs recovered 88.5% and 84.4% of AMX from tap water spiked at 10 and 50 mg L−1, respectively, and 83.5% and 81.0% from synthetic municipal wastewater spiked at the same concentrations, with RSD values below 5%. The adsorbent further retained 94% of its initial capacity after five adsorption–desorption cycles. This work establishes a scalable green route for producing high-quality MSNs and demonstrates the feasibility of the resulting silanol-rich mesoporous nano-adsorbents for pharmaceutical micropollutant removal, while also indicating their potential suitability as carrier platforms for drug-delivery applications.